Although antimicrobial resistance represents a major global
health concern, investment by large pharmaceutical companies in antibiotic
development has steadily declined. In contrast, research spending remains high
in fields such as oncology, autoimmune disease, and metabolic disorders.

Which consideration most strongly contributes to this disparity
in investment?

Question

Although antimicrobial resistance represents a major global
health concern, investment by large pharmaceutical companies in antibiotic
development has steadily declined. In contrast, research spending remains high
in fields such as oncology, autoimmune disease, and metabolic disorders.

Which consideration most strongly contributes to this disparity
in investment?

Accepted Answer

Antibiotics
usually offer lower commercial returns because they are taken for short courses
and their use is deliberately restricted to preserve efficacy

Answer

Drug
companies no longer possess the specialized knowledge required to develop
antimicrobials

Answer

Modern
antimicrobial research faces insurmountable scientific barriers that are absent
in other therapeutic areas

Answer

Severe
bacterial infections are now uncommon in developed countries, reducing clinical
demand

Crowdly

Although antimicrobial resistance represents a major global health concern, inv...

Want instant access to all verified answers on learning.monash.edu?